NDC 41415-994 – Guaifenesin and Pseudoephedrine Hydrochloride
Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral
Product NDC41415-994
Product details
- Brand name
- Guaifenesin and Pseudoephedrine Hydrochloride
- Generic name
- Guaifenesin and Pseudoephedrine Hydrochloride
- Labeler
- PUBLIX SUPER MARKETS, INC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA212542
- Marketed since
- April 7, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Expectorant; alpha-Adrenergic Agonist
Active ingredients
- Guaifenesin 600 mg/1
- Pseudoephedrine Hydrochloride 60 mg/1
Uses, dosage, side effects and warnings for Guaifenesin and Pseudoephedrine Hydrochloride →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 41415-994-18 | 1 BLISTER PACK in 1 CARTON (41415-994-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 7, 2022 |
| 41415-994-36 | 2 BLISTER PACK in 1 CARTON (41415-994-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Apr 7, 2022 |
Other Guaifenesin and Pseudoephedrine Hydrochloride products
- 62011-0475 Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · STRATEGIC SOURCING SERVICES LLC
- 0363-0077 Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · WALGREEN COMPANY